日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Triple-positive non-small cell lung cancer harboring EGFR mutation, ALK rearrangement, and high PD-L1 expression: a case report and literature review

三阳性非小细胞肺癌伴EGFR突变、ALK重排和PD-L1高表达：病例报告及文献复习

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2025.1727899
Mao, Mengjie; Tao, Qingxiu; Zuo, Zhuo; Ge, Jun; Tian, Yuke; Liu, Bin
肺癌
肿瘤
肿瘤免疫
ALK
EGF
PD-L1
EGFR
细胞生物学
发表日期：2025
文献求助 收藏

Diagnosis of acute Q fever using targeted next‑generation sequencing: A case report

利用靶向二代测序诊断急性Q热：病例报告

期刊:
影响因子:
doi:10.3892/etm.2024.12764
Jiang, Zongchen; Yan, Zimin; Yang, Yebeilei; Tian, Yuke; Zhao, Xin; Liu, Xiaoyu; Bai, Yang; Zhang, Litai; Yang, Jinliang; Ma, Rong; Geng, Yanting; He, Long; Wang, Yinghui
发表日期：2025
文献求助 收藏

A clinical-information-free method for early diagnosis of lung cancer from the patients with pulmonary nodules based on backpropagation neural network model

基于反向传播神经网络模型的肺结节患者肺癌早期诊断的无临床信息方法

期刊:Computational and Structural Biotechnology Journal
影响因子:4.1
doi:10.1016/j.csbj.2024.05.010
Yang, Xin; Wu, Changchun; Liu, Wenwen; Fu, Kaiyu; Tian, Yuke; Wei, Xing; Zhang, Wei; Sun, Ping; Luo, Huaichao; Huang, Jian
肺癌
肿瘤
肿瘤免疫
发表日期：2024
文献求助 收藏

Development and validation of a novel prognostic nomogram for advanced diffuse large B cell lymphoma

开发和验证一种用于晚期弥漫性大B细胞淋巴瘤的新型预后列线图

期刊:Clinical and Experimental Medicine
影响因子:3.5
doi:10.1007/s10238-024-01326-y
Wan, Mengdi; Zhang, Wei; Huang, He; Fang, Xiaojie; Chen, Yungchang; Tian, Ying; Yao, Yuyi; Weng, Huawei; Chen, Zegeng; Yu, Le; Tian, Yuke; Huang, Huageng; Li, Xudong; Hong, Huangming; Lin, Tongyu
B细胞
细胞生物学
淋巴瘤
免疫/内分泌
发表日期：2024
文献求助 收藏

Real-world clinical analysis in 190 advanced NSCLC patients with uncommon EGFR mutations: A multi-center study

一项针对190例携带罕见EGFR突变的晚期非小细胞肺癌患者的真实世界临床分析：一项多中心研究

期刊:Cancer Science
影响因子:4.3
doi:10.1111/cas.15769
Qin, Yi; Long, Yaling; Tang, Yuan; Tian, Yuke; Li, Juan; Duan, Ping; Luo, Jieyan; Yu, Min; Li, Yanying; Zhou, Xiaojuan; Wang, Ke; Gong, Youling; Peng, Feng; Zhu, Jiang; Liu, Yongmei; Zhou, Lin; Lu, You; Huang, Meijuan
肺癌
肿瘤
肿瘤免疫
EGF
EGFR
细胞生物学
发表日期：2023
文献求助 收藏

Anlotinib plus chemotherapy for T790M-negative EGFR-mutant non-sqNSCLC resistant to TKIs: A multicenter phase 1b/2 trial

安罗替尼联合化疗治疗对TKI耐药的T790M阴性EGFR突变型非鳞状非小细胞肺癌：一项多中心1b/2期试验

期刊:Thoracic Cancer
影响因子:2.3
doi:10.1111/1759-7714.14713
Li, Juan; Tian, Yuke; Zheng, Min; Ge, Jun; Zhang, Jiliang; Kong, Dejun; Chen, Mei; Yu, Ping
肺癌
肿瘤
肿瘤免疫
EGF
EGFR
细胞生物学
发表日期：2022
文献求助 收藏

BRAF V600E Mediates Crizotinib Resistance and Responds to Dabrafenib and Trametinib in a ROS1-Rearranged Non-Small Cell Lung Cancer: A Case Report

BRAF V600E介导克唑替尼耐药，但ROS1重排的非小细胞肺癌对达拉非尼和曲美替尼有反应：病例报告

期刊:Oncologist
影响因子:4.2
doi:10.1002/onco.13979
Li, Juan; Wang, Qifeng; Ge, Jun; Tian, Yuke; Yao, Wenxiu
肺癌
肿瘤
肿瘤免疫
BRAF
细胞生物学
发表日期：2021
文献求助 收藏

Potential predictive value of plasma heat shock protein 90α in lung cancer

血浆热休克蛋白90α在肺癌中的潜在预测价值

期刊:Journal of International Medical Research
影响因子:1.5
doi:10.1177/03000605211064393
Li, Xiaoqian; Tong, Xuesong; Liu, Bin; Li, Zeng; Ding, Jing; Li, Jiang; Zheng, Min; Tian, Yuke; Yan, Siyou; Huang, Meiling; Ge, Jun
肺癌
肿瘤
肿瘤免疫
发表日期：2021
文献求助 收藏

FOXL2 expression might be a novel prognostic biomarker in patients with laryngeal squamous cell carcinoma

FOXL2表达可能是喉鳞状细胞癌患者的一种新型预后生物标志物

期刊:Journal of International Medical Research
影响因子:1.5
doi:10.1177/0300060520919252
Ge, Jun; Jiang, Li; Tian, Yuke; Zheng, Min; Huang, Meiling; Li, Juan
FOXL2
细胞生物学
肿瘤
肿瘤免疫
发表日期：2020
文献求助 收藏

[Safety and Preliminary Efficacy of Ceritinib 450 mg with Food in Chinese ALK-positive Non-small Cell Lung Cancer]

【色瑞替尼450mg与食物同服治疗中国ALK阳性非小细胞肺癌患者的安全性和初步疗效】

期刊:Chinese Journal of Lung Cancer
影响因子:
doi:10.3779/j.issn.1009-3419.2020.102.33
Tian, Yuke; Tian, Tian; Yu, Ping; Ren, Li; Gong, Youling; Yao, Wenxiu; Zhang, Xi; Yin, Jun; He, Lang; Chen, Li; Wang, Ke; Huang, Meijuan; Li, Juan
肺癌
肿瘤
肿瘤免疫
ALK
细胞生物学
发表日期：2020
文献求助 收藏